Back to Search Start Over

Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.

Authors :
Schneider RK
Ademà V
Heckl D
Järås M
Mallo M
Lord AM
Chu LP
McConkey ME
Kramann R
Mullally A
Bejar R
Solé F
Ebert BL
Source :
Cancer cell [Cancer Cell] 2014 Oct 13; Vol. 26 (4), pp. 509-20. Date of Electronic Publication: 2014 Sep 18.
Publication Year :
2014

Abstract

The casein kinase 1A1 gene (CSNK1A1) is a putative tumor suppressor gene located in the common deleted region for del(5q) myelodysplastic syndrome (MDS). We generated a murine model with conditional inactivation of Csnk1a1 and found that Csnk1a1 haploinsufficiency induces hematopoietic stem cell expansion and a competitive repopulation advantage, whereas homozygous deletion induces hematopoietic stem cell failure. Based on this finding, we found that heterozygous inactivation of Csnk1a1 sensitizes cells to a CSNK1 inhibitor relative to cells with two intact alleles. In addition, we identified recurrent somatic mutations in CSNK1A1 on the nondeleted allele of patients with del(5q) MDS. These studies demonstrate that CSNK1A1 plays a central role in the biology of del(5q) MDS and is a promising therapeutic target.<br /> (Copyright © 2014 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1878-3686
Volume :
26
Issue :
4
Database :
MEDLINE
Journal :
Cancer cell
Publication Type :
Academic Journal
Accession number :
25242043
Full Text :
https://doi.org/10.1016/j.ccr.2014.08.001